Chlorotoxin Recruiting Phase 1 Trials for Recurrent Glioblastoma / Recurrent WHO Grade III Glioma / Recurrent WHO Grade II Glioma / Recurrent Malignant Gliomas Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT04214392Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma